collection
Collections Essential Urology

Essential Urology

Just essential articles for your daily practice.

https://read.qxmd.com/read/33551297/outcomes-of-a-noninferiority-randomised-controlled-trial-of-surgery-for-men-with-urodynamic-stress-incontinence-after-prostate-surgery-master
#1
RANDOMIZED CONTROLLED TRIAL
Paul Abrams, Lynda D Constable, David Cooper, Graeme MacLennan, Marcus J Drake, Chris Harding, Anthony Mundy, Kirsty McCormack, Alison McDonald, John Norrie, Craig Ramsay, Rebecca Smith, Nikki Cotterill, Mary Kilonzo, Cathryn Glazener
BACKGROUND: Stress urinary incontinence (SUI) is common after radical prostatectomy and likely to persist despite conservative treatment. The sling is an emerging operation for persistent SUI, but randomised controlled trial (RCT) comparison with the established artificial urinary sphincter (AUS) is lacking. OBJECTIVE: To compare the outcomes of surgery in men with bothersome urodynamic SUI after prostate surgery. DESIGN, SETTING, AND PARTICIPANTS: A noninferiority RCT was conducted among men with bothersome urodynamic SUI from 27 UK centres...
June 2021: European Urology
https://read.qxmd.com/read/33484823/efficacy-and-safety-of-vibegron-add-on-therapy-in-men-with-persistent-storage-symptoms-after-receiving-alpha-1-blocker-or-phosphodiesterase-5-inhibitor-a-preliminary-study
#2
JOURNAL ARTICLE
Keisuke Ishikawa, Akira Tsujimura, Miho Miyoshi, Yuto Miyoshi, Taiki Ogasa, Ippei Hiramatsu, Yuka Uesaka, Taiji Nozaki, Masato Shirai, Isao Mitsuhashi, Sosuke Sugimura, Taiki Mizuno, Kensho Noto, Yasuhiro Shigeta, Shinichi Honda, Shinji Iwata, Shigeo Horie
OBJECTIVE: To investigate the efficacy and safety of vibegron add-on therapy in men with persistent storage symptoms receiving α-1 blockers or PDE5 inhibitor for benign prostatic hyperplasia and then determine the independent factors affecting the efficacy of vibegron. METHODS: Vibegron 50 mg was administered for 12 weeks to 42 patients (72.0 ± 8.2 years) with persistent storage symptoms who had taken α-1 blockers (22 patients) or PDE5 inhibitor (20 patients)...
July 2021: Urology
https://read.qxmd.com/read/33458786/tea-and-coffee-consumption-and-the-risk-of-urinary-stones-a-systematic-review-of-the-epidemiological-data
#3
JOURNAL ARTICLE
Yazeed Barghouthy, Mariela Corrales, Steeve Doizi, Bhaskar K Somani, Olivier Traxer
OBJECTIVE: To explore the relationship between the consumption of coffee and tea with urolithiasis. We evaluated large epidemiological and small clinical studies to draw conclusions regarding their lithogenic risk. METHODS: A systematic review was performed using the Medline and Scopus databases, in concordance with the PRISMA statement. English, French, and Spanish language studies regarding the consumption of caffeinated and decaffeinated coffee and tea, and the relationship to urinary stone disease were reviewed...
August 2021: World Journal of Urology
https://read.qxmd.com/read/32945632/avelumab-maintenance-therapy-for-advanced-or-metastatic-urothelial-carcinoma
#4
RANDOMIZED CONTROLLED TRIAL
Thomas Powles, Se Hoon Park, Eric Voog, Claudia Caserta, Begoña P Valderrama, Howard Gurney, Haralabos Kalofonos, Siniša Radulović, Wim Demey, Anders Ullén, Yohann Loriot, Srikala S Sridhar, Norihiko Tsuchiya, Evgeny Kopyltsov, Cora N Sternberg, Joaquim Bellmunt, Jeanny B Aragon-Ching, Daniel P Petrylak, Robert Laliberte, Jing Wang, Bo Huang, Craig Davis, Camilla Fowst, Nuno Costa, John A Blake-Haskins, Alessandra di Pietro, Petros Grivas
BACKGROUND: Platinum-based chemotherapy is standard-of-care first-line treatment for advanced urothelial carcinoma. However, progression-free survival and overall survival are limited by chemotherapy resistance. METHODS: In a phase 3 trial, we randomly assigned patients with unresectable locally advanced or metastatic urothelial cancer who did not have disease progression with first-line chemotherapy (four to six cycles of gemcitabine plus cisplatin or carboplatin) to receive best supportive care with or without maintenance avelumab...
September 24, 2020: New England Journal of Medicine
https://read.qxmd.com/read/33461781/a-systematic-review-of-patients-values-preferences-and-expectations-for-the-diagnosis-and-treatment-of-male-lower-urinary-tract-symptoms
#5
JOURNAL ARTICLE
Sachin Malde, Roland Umbach, Jessica R Wheeler, Lyubov Lytvyn, Jean-Nicholas Cornu, Mauro Gacci, Christian Gratzke, Thomas R W Herrmann, Charalampos Mamoulakis, Malte Rieken, Mark J Speakman, Stavros Gravas, Marcus J Drake, Gordon H Guyatt, Kari A O Tikkinen
CONTEXT: Understanding men's values and preferences in the context of personal, physical, emotional, relational, and social factors is important in optimising patient counselling, facilitating treatment decision-making, and improving guideline recommendations. OBJECTIVE: To systematically review the available evidence regarding the values, preferences, and expectations of men towards the investigation and treatment (conservative, pharmacological, and surgical) of male lower urinary tract symptoms (LUTS)...
June 2021: European Urology
https://read.qxmd.com/read/33449575/modern-surgical-strategies-in-the-management-of-complex-ureteral-strictures
#6
REVIEW
Pia Paffenholz, Axel Heidenreich
PURPOSE OF REVIEW: The purpose of this article is to outline the various therapeutic options of ureteral strictures. RECENT FINDINGS: Ureteral strictures with consecutive hydronephrosis can be due to endourological and surgical procedures, inflammatory processes, radiation therapy as well as spontaneous passage of ureteral calculi. When planning surgical correction, stricture length, anatomical location as well as patients' characteristics like age, comorbidities and previous treatment in the peritoneal cavity, retroperitoneum or pelvis should be taken into consideration...
March 1, 2021: Current Opinion in Urology
https://read.qxmd.com/read/33452911/available-active-surveillance-follow-up-protocols-for-small-renal-mass-a-systematic-review
#7
JOURNAL ARTICLE
Giacomo Rebez, Nicola Pavan, M Carmen Mir
PURPOSE: To evaluate follow-up strategies for active surveillance of renal masses and to assess contemporary data. METHODS: We performed a comprehensive search of electronic databases (Embase, Medline, and Cochrane). A systematic review of the follow-up protocols was carried out. A total of 20 studies were included. RESULT: Our analysis highlights that most of the series used different protocols of follow-up without consistent differences in the outcomes...
August 2021: World Journal of Urology
https://read.qxmd.com/read/33402296/beyond-antimuscarinics-a-review-of-pharmacological-and-interventional-options-for-overactive-bladder-management-in-men
#8
JOURNAL ARTICLE
Cosimo De Nunzio, Benjamin Brucker, Thomas Bschleipfer, Jean-Nicolas Cornu, Marcus J Drake, Ferdinando Fusco, Stavros Gravas, Matthias Oelke, Benoit Peyronnet, Manuela Tutolo, Gommert van Koeveringe, Stephan Madersbacher
CONTEXT: The role of overactive bladder (OAB) treatment in women beyond antimuscarinics has been evaluated extensively. Beta-3 agonists, botulinum toxin-A (BTX-A), and nerve stimulation are indicated in these patients. However, data on male patients in this clinical scenario are scarce. OBJECTIVE: The aim of this systematic review was to evaluate the evidence on treatment options beyond antimuscarinics in men with OAB. EVIDENCE ACQUISITION: A search of PubMed, EMBASE, Scopus, Web of science, Cochrane Central Register of Controlled Trials, and Cochrane Central Database of Systematic Reviews databases was performed for relevant articles published between January 2000 and October 2020, using the following Medical Subject Headings: "male/man," "LUTS," "overactive bladder," "storage symptoms," "urgency," "nocturia," "incontinence," "beta-3 agonist," "PDE-5 inhibitors," "botulinum toxin," "sacral nerve stimulation/neurostimulation," "percutaneous/transcutaneous tibial nerve stimulation," "PTENS," and "combination therapy...
April 2021: European Urology
https://read.qxmd.com/read/33284711/does-ureteral-stenting-increase-the-risk-of-metachronous-upper-tract-urothelial-carcinoma-in-patients-with-bladder-tumors-a-systematic-review-and-meta-analysis
#9
JOURNAL ARTICLE
Petros Sountoulides, Nikolaos Pyrgidis, Sabine Brookman-May, Ioannis Mykoniatis, Theofilos Karasavvidis, Dimitrios Hatzichristou
PURPOSE: Ureteral stenting in patients with bladder cancer may become necessary in order to protect the ureteral orifice during transurethral resection of the tumor or for relief of upper urinary tract obstruction. However, it is believed to increase metachronous upper tract urothelial carcinoma risk. MATERIALS AND METHODS: We performed a systematic review and meta-analysis of studies comparing ureteral stenting versus nephrostomy or no drainage with regard to the risk of metachronous upper tract urothelial carcinoma...
April 2021: Journal of Urology
https://read.qxmd.com/read/33356483/evaluation-of-the-new-american-urological-association-guidelines-risk-classification-for-hematuria
#10
JOURNAL ARTICLE
Solomon L Woldu, Casey K Ng, Ronald K Loo, Jeff M Slezak, Steven J Jacobsen, Wei Shen Tan, John D Kelly, Tony Lough, David Darling, Kim E M van Kessel, Joep J de Jong, Wim van Criekinge, Shahrokh F Shariat, Andrew Hiar, Sarah Brown, Stephen A Boorjian, Daniel A Barocas, Robert S Svatek, Yair Lotan
PURPOSE: Microhematuria is a prevalent condition and the American Urological Association has developed a new risk-stratified approach for the evaluation of patients with microhematuria. Our objective was to provide the first evaluation of this important guideline. MATERIALS AND METHODS: This multinational cohort study combines contemporary patients from 5 clinical trials and 2 prospective registries who underwent urological evaluation for hematuria. Patients were stratified into American Urological Association risk strata (low, intermediate or high risk) based on sex, age, degree of hematuria, and smoking history...
May 2021: Journal of Urology
https://read.qxmd.com/read/33285214/a-visual-scale-for-improving-communication-when-describing-gross-hematuria
#11
JOURNAL ARTICLE
Thomas E Stout, Michael Borofsky, Ayman Soubra
OBJECTIVE: To create and validate a grading scale that facilitates communication between providers managing gross hematuria (GH). METHODS: A blood simulant was used to create a spectrum of GH in 5 foley catheter tubes which were shown to a group of experienced urologists. The urologists were asked how they would adjust the continuous bladder irrigation rate if the samples represented the urine of hypothetical patients, and a 5-point scale was created by group consensus with pictures of the representative tubes printed onto a visual aid...
February 2021: Urology
https://read.qxmd.com/read/32411212/efficacy-of-tamsulosin-plus-tadalafil-versus-tamsulosin-as-medical-expulsive-therapy-for-lower-ureteric-stones-a-randomized-controlled-trial
#12
JOURNAL ARTICLE
Diwas Gnyawali, Manish Man Pradhan, Prem Raj Sigdel, Purushottam Parajuli, Sampanna Chudal, Sujeet Poudyal, Suman Chapagain, Bhoj Raj Luitel, Pawan Raj Chalise, Uttam Sharma, Prem Raj Gyawali
INTRODUCTION: Urolithiasis is one of the common disorder with which about 1/5th is found in the ureter, of which 2/3rd is seen in the lower ureter. Medical expulsive therapy is one of the routine modalities of treatment which uses various drugs acting on the ureter smooth muscle by different mechanism. We aim to compare the efficacy of combination vs. single drug. METHODS: This randomized controlled trial was done in 176 consecutive patients over a period of six months (March 2019 to August 2019) in Department of Urology and Kidney Transplant Surgery, Tribhuvan University Teaching...
2020: Advances in Urology
https://read.qxmd.com/read/33218826/robot-assisted-radical-nephrectomy-a-systematic-review-and-meta-analysis-of-comparative-studies
#13
JOURNAL ARTICLE
Fabio Crocerossa, Umberto Carbonara, Francesco Cantiello, Michele Marchioni, Pasquale Ditonno, Maria C Mir, Francesco Porpiglia, Ithaar Derweesh, Lance J Hampton, Rocco Damiano, Riccardo Autorino
CONTEXT: Radical nephrectomy (RN) is the gold standard treatment for large and locally advanced renal tumors. Although robot-assisted radical nephrectomy (RRN) is being increasingly adopted, it remains unclear whether it offers benefits over standard laparoscopic radical nephrectomy (LRN) or open radical nephrectomy (ORN). OBJECTIVE: To compare the outcomes of robotic surgery to those of laparoscopic and open surgery in patients undergoing RN for renal cell carcinoma (RCC)...
October 2021: European Urology
https://read.qxmd.com/read/33218590/current-trends-in-artificial-intelligence-application-for-endourology-and-robotic-surgery
#14
REVIEW
Timothy C Chang, Caleb Seufert, Okyaz Eminaga, Eugene Shkolyar, Jim C Hu, Joseph C Liao
With the advent of electronic medical records and digitalization of health care over the past 2 decades, artificial intelligence (AI) has emerged as an enabling tool to manage complex datasets and deliver streamlined data-driven patient care. AI algorithms have the ability to extract meaningful signal from complex datasets through an iterative process akin to human learning. Through advancements over the past decade in deep learning, AI-driven innovations have accelerated applications in health care. Herein, the authors explore the development of these emerging AI technologies, focusing on the application of AI to endourology and robotic surgery...
February 2021: Urologic Clinics of North America
https://read.qxmd.com/read/33258891/urinary-diversion
#15
Andrew T Lenis, Patrick M Lec, Karim Chamie
No abstract text is available yet for this article.
December 1, 2020: JAMA
https://read.qxmd.com/read/33185708/holep-after-prostate-biopsy-does-it-have-any-impact
#16
JOURNAL ARTICLE
Sercan Yılmaz, Engin Kaya, Eymen Gazel, Serdar Yalcın, Halil Cagrı Aybal, Mehmet Yılmaz, Onur Açıkgöz, Hakan Özdemir, Lutfi Tunc
PURPOSE: Holmium laser enucleation of the prostate (HoLEP) has recently become the recommended treatment for prostate in all sizes in benign prostate hyperplasia surgery. A recent prostate biopsy performed prior to the HoLEP procedure can make surgeons concerned about the surgery. We aimed to investigate the per- and postoperative outcomes of the HoLEP procedure in patients who underwent prostate biopsy and to evaluate the most appropriate surgery time after biopsy. METHODS: The data of 160 patients who underwent HoLEP by a single surgeon between March 2017 and December 2019 were retrospectively reviewed...
July 2021: World Journal of Urology
https://read.qxmd.com/read/33201204/detection-of-pathogenic-variants-with-germline-genetic-testing-using-deep-learning-vs-standard-methods-in-patients-with-prostate-cancer-and-melanoma
#17
COMPARATIVE STUDY
Saud H AlDubayan, Jake R Conway, Sabrina Y Camp, Leora Witkowski, Eric Kofman, Brendan Reardon, Seunghun Han, Nicholas Moore, Haitham Elmarakeby, Keyan Salari, Hani Choudhry, Abdullah M Al-Rubaish, Abdulsalam A Al-Sulaiman, Amein K Al-Ali, Amaro Taylor-Weiner, Eliezer M Van Allen
Importance: Less than 10% of patients with cancer have detectable pathogenic germline alterations, which may be partially due to incomplete pathogenic variant detection. Objective: To evaluate if deep learning approaches identify more germline pathogenic variants in patients with cancer. Design, Setting, and Participants: A cross-sectional study of a standard germline detection method and a deep learning method in 2 convenience cohorts with prostate cancer and melanoma enrolled in the US and Europe between 2010 and 2017...
November 17, 2020: JAMA
https://read.qxmd.com/read/33201207/bladder-cancer-a-review
#18
REVIEW
Andrew T Lenis, Patrick M Lec, Karim Chamie, M D Mshs
IMPORTANCE: Bladder cancer is a common malignancy in women and is the fourth most common malignancy in men. Bladder cancer ranges from unaggressive and usually noninvasive tumors that recur and commit patients to long-term invasive surveillance, to aggressive and invasive tumors with high disease-specific mortality. OBSERVATIONS: Advanced age, male sex, and cigarette smoking contribute to the development of bladder cancer. Bladder tumors can present with gross or microscopic hematuria, which is evaluated with cystoscopy and upper tract imaging depending on the degree of hematuria and risk of malignancy...
November 17, 2020: JAMA
https://read.qxmd.com/read/33153953/nocebo-response-in-the-pharmacological-management-of-overactive-bladder-a-systematic-review-and-meta-analysis
#19
REVIEW
Hadi Mostafaei, Keiichiro Mori, Fahad Quhal, Noriyoshi Miura, Reza Sari Motlagh, Benjamin Pradere, Ekaterina Laukhtina, Ivan Lysenko, Sajjad Ghaffari, Sakineh Hajebrahimi, Shahrokh F Shariat
CONTEXT: The role of a nocebo response in managing urology patients is unclear. OBJECTIVE: To assess the nocebo response in randomized placebo-controlled overactive bladder (OAB) trials of pharmacological treatment by investigating the adverse events in the placebo arms. EVIDENCE ACQUISITION: PubMed, Scopus, Embase, and Cochrane Central Register of Controlled Trials were searched to identify potential randomized controlled trials published from 1998 to November 2019...
September 2021: European Urology Focus
https://read.qxmd.com/read/33172724/eau-eanm-estro-esur-siog-guidelines-on-prostate-cancer-2020-update-part-1-screening-diagnosis-and-local-treatment-with-curative-intent
#20
JOURNAL ARTICLE
Nicolas Mottet, Roderick C N van den Bergh, Erik Briers, Thomas Van den Broeck, Marcus G Cumberbatch, Maria De Santis, Stefano Fanti, Nicola Fossati, Giorgio Gandaglia, Silke Gillessen, Nikos Grivas, Jeremy Grummet, Ann M Henry, Theodorus H van der Kwast, Thomas B Lam, Michael Lardas, Matthew Liew, Malcolm D Mason, Lisa Moris, Daniela E Oprea-Lager, Henk G van der Poel, Olivier Rouvière, Ivo G Schoots, Derya Tilki, Thomas Wiegel, Peter-Paul M Willemse, Philip Cornford
OBJECTIVE: To present a summary of the 2020 version of the European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-International Society of Geriatric Oncology (SIOG) guidelines on screening, diagnosis, and local treatment of clinically localised prostate cancer (PCa). EVIDENCE ACQUISITION: The panel performed a literature review of new data, covering the time frame between 2016 and 2020...
February 2021: European Urology
label_collection
label_collection
1413
1
2
2020-11-16 08:34:03
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.